0001209191-16-133688.txt : 20160722 0001209191-16-133688.hdr.sgml : 20160722 20160722141149 ACCESSION NUMBER: 0001209191-16-133688 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160720 FILED AS OF DATE: 20160722 DATE AS OF CHANGE: 20160722 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BOGER JOSHUA S CENTRAL INDEX KEY: 0001197023 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 161779405 MAIL ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-07-20 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001197023 BOGER JOSHUA S C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 1 0 0 0 Common Stock 2016-07-20 4 M 0 6500 36.30 A 274725 D Common Stock 2016-07-20 4 S 0 300 87.69 D 274425 D Common Stock 2016-07-20 4 S 0 600 88.92 D 273825 D Common Stock 2016-07-20 4 S 0 2600 90.28 D 271225 D Common Stock 2016-07-20 4 S 0 3000 90.91 D 268225 D Common Stock 13286 I 401k Common Stock 122700 I Common Stock Held In Trust Stock Option (Right to Buy) 36.30 2016-07-20 4 M 0 6500 0.00 D 2017-01-23 Common Stock 6500 164000 D Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1. Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $87.69 (range $87.17 to $88.06). Open market sales reported on this line occurred at a weighted average price of $88.92 (range $88.42 to $89.30). Open market sales reported on this line occurred at a weighted average price of $90.28 (range $89.62 to $90.61). Open market sales reported on this line occurred at a weighted average price of $90.91 (range $90.62 to $91.19). Fully vested. Omar White, Attorney-In-Fact 2016-07-22